dc.contributor.author |
Atakov S.S., Okhunov A.O., Bobokulova Sh.A., Kasimov U.K., Bobabekov A.R. |
|
dc.date.accessioned |
2022-12-01T04:46:47Z |
|
dc.date.available |
2022-12-01T04:46:47Z |
|
dc.date.issued |
2022-11-30 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/4705 |
|
dc.description.abstract |
Suppurative diseases of the lungs are topical issues of pulmonology that require detailed study due to
the difficulties of diagnosis and high mortality of patients. This is due to several objective and subjective
reasons such as the widespread use of antibioticresistant microflora, which is especially important when
antibiotics are prescribed unreasonably, even with a mild form of COVID − 19. This, of course, affects
COVID patients, who already have reduced immunity. The question of the exact mechanism of
development of purulent complications of the lungs after or during infection with COVID − 19 remains
open. Clinical and radiological signs of a lung abscess often resemble the symptoms of pneumonia;
however, antibacterial, and symptomatic therapy have differences. With gangrene of the lung, the
increase in intoxication syndrome can be gradual, which reduces the doctor's alertness regarding the
most severe disease and causes inadequate therapy. Comprehensive diagnostic measures, knowledge of
the main clinical, instrumental and laboratory parameters are necessary for all physicians. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Европа |
en_US |
dc.subject |
acute lung abscesses, lung gangrene, diagnostics, microbiology, sparing methods of treatment |
en_US |
dc.title |
Difficult Aspects of Treatments Patients With Acute Lung Abscesses Who Survived COVID -19 |
en_US |
dc.type |
Article |
en_US |